| 2.0 |
5.9 |
GO:1903609 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.8 |
5.5 |
GO:0000961 |
negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.5 |
4.6 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 1.4 |
4.1 |
GO:0000921 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 1.3 |
5.3 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.3 |
3.9 |
GO:0070512 |
regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 1.2 |
5.0 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 1.2 |
3.5 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.1 |
1.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.1 |
2.3 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 1.1 |
3.2 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 1.1 |
3.2 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 1.0 |
1.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 1.0 |
5.2 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.0 |
3.1 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 1.0 |
6.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.0 |
1.0 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 1.0 |
4.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.0 |
6.9 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.0 |
3.0 |
GO:0051300 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 1.0 |
3.9 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 1.0 |
4.9 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 1.0 |
2.9 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.9 |
0.9 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.9 |
8.4 |
GO:1902966 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.9 |
3.7 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.9 |
5.5 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.9 |
4.6 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.9 |
2.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.9 |
3.6 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.9 |
3.6 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.9 |
3.6 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.9 |
2.7 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.9 |
2.7 |
GO:0060931 |
sinoatrial node cell development(GO:0060931) |
| 0.9 |
2.7 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.9 |
9.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.8 |
2.5 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.8 |
4.2 |
GO:1902904 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.8 |
5.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.8 |
2.5 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.8 |
3.3 |
GO:1904793 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.8 |
4.1 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.8 |
0.8 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.8 |
1.6 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.8 |
3.2 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.8 |
6.3 |
GO:1990262 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.8 |
2.4 |
GO:0061738 |
late endosomal microautophagy(GO:0061738) |
| 0.8 |
4.7 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.8 |
3.9 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.8 |
17.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.8 |
2.3 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.8 |
3.0 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.8 |
2.3 |
GO:0071301 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.8 |
0.8 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.8 |
1.5 |
GO:0033023 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.7 |
2.2 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.7 |
2.2 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.7 |
2.2 |
GO:0071262 |
regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.7 |
2.9 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.7 |
3.6 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.7 |
5.0 |
GO:2000567 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.7 |
2.9 |
GO:0097069 |
cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.7 |
1.4 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.7 |
4.9 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.7 |
0.7 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.7 |
2.1 |
GO:0015728 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.7 |
2.8 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.7 |
0.7 |
GO:0031081 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.7 |
3.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.7 |
2.7 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.7 |
1.4 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.7 |
2.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.7 |
5.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 0.7 |
1.3 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.7 |
3.3 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.7 |
3.3 |
GO:0021649 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.7 |
2.0 |
GO:1903515 |
calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.7 |
0.7 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.7 |
1.3 |
GO:0042640 |
anagen(GO:0042640) regulation of anagen(GO:0051884) |
| 0.7 |
2.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.7 |
4.0 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.7 |
6.6 |
GO:2001166 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.7 |
0.7 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.7 |
2.0 |
GO:0000479 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.7 |
2.6 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.7 |
9.1 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.7 |
5.9 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.6 |
3.9 |
GO:0002225 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.6 |
5.2 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.6 |
2.6 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.6 |
3.8 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.6 |
1.9 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.6 |
1.9 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.6 |
3.8 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 |
2.5 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.6 |
0.6 |
GO:1900063 |
regulation of peroxisome organization(GO:1900063) |
| 0.6 |
7.5 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.6 |
0.6 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.6 |
1.2 |
GO:0036215 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 |
1.8 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.6 |
1.2 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.6 |
3.7 |
GO:0070982 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.6 |
1.8 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.6 |
4.2 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.6 |
1.2 |
GO:0071673 |
positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.6 |
2.4 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.6 |
2.4 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.6 |
1.8 |
GO:0098972 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.6 |
0.6 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.6 |
1.8 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.6 |
0.6 |
GO:0061441 |
renal artery morphogenesis(GO:0061441) |
| 0.6 |
1.2 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.6 |
2.3 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.6 |
2.9 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.6 |
1.7 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.6 |
0.6 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.6 |
2.9 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.6 |
0.6 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.6 |
4.6 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.6 |
2.9 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.6 |
10.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.6 |
1.7 |
GO:0032904 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.6 |
2.3 |
GO:0019860 |
uracil metabolic process(GO:0019860) |
| 0.6 |
5.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.6 |
2.8 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.6 |
3.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.6 |
1.7 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.6 |
2.8 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.6 |
1.7 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 0.6 |
2.2 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.6 |
2.2 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.6 |
3.3 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.6 |
1.7 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.6 |
0.6 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.6 |
7.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.6 |
2.8 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.5 |
2.2 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.5 |
1.6 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.5 |
1.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.5 |
2.2 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.5 |
2.7 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 |
0.5 |
GO:1901420 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
| 0.5 |
4.9 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.5 |
0.5 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.5 |
2.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.5 |
2.7 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.5 |
5.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.5 |
1.1 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.5 |
1.1 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.5 |
1.6 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.5 |
1.6 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.5 |
5.3 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.5 |
1.6 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.5 |
2.1 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 |
2.1 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.5 |
1.6 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.5 |
1.0 |
GO:2000374 |
regulation of oxygen metabolic process(GO:2000374) |
| 0.5 |
1.6 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 |
4.2 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.5 |
2.6 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.5 |
1.5 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.5 |
1.5 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 |
0.5 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.5 |
5.1 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.5 |
7.1 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.5 |
3.1 |
GO:1901909 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.5 |
2.5 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.5 |
1.5 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.5 |
0.5 |
GO:1902823 |
negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.5 |
2.0 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.5 |
0.5 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.5 |
3.5 |
GO:0043387 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.5 |
2.5 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.5 |
1.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.5 |
6.0 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.5 |
5.0 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.5 |
4.0 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.5 |
3.0 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.5 |
9.4 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.5 |
1.5 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.5 |
5.9 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.5 |
2.0 |
GO:2000053 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.5 |
2.0 |
GO:0031049 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.5 |
1.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.5 |
1.5 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.5 |
3.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.5 |
1.0 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.5 |
7.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.5 |
3.4 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.5 |
0.5 |
GO:0014075 |
response to amine(GO:0014075) |
| 0.5 |
1.5 |
GO:2000283 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.5 |
1.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.5 |
1.9 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.5 |
2.4 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.5 |
1.9 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.5 |
1.9 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.5 |
1.9 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.5 |
1.9 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 |
2.9 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.5 |
1.0 |
GO:0048565 |
digestive tract development(GO:0048565) |
| 0.5 |
1.4 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.5 |
5.7 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.5 |
1.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.5 |
1.9 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.5 |
2.4 |
GO:0006045 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.5 |
1.4 |
GO:0003249 |
cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.5 |
1.4 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.5 |
5.6 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.5 |
1.4 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.5 |
0.9 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.5 |
0.5 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.5 |
2.8 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.5 |
3.3 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.5 |
0.5 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.5 |
1.4 |
GO:0033488 |
cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.5 |
7.4 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.5 |
1.9 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.5 |
2.8 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.5 |
1.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
0.9 |
GO:0072019 |
proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.5 |
0.5 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.5 |
1.8 |
GO:1905216 |
positive regulation of RNA binding(GO:1905216) |
| 0.5 |
1.4 |
GO:1990426 |
homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.5 |
0.5 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.5 |
1.4 |
GO:0042040 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.5 |
1.8 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.5 |
1.4 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.5 |
5.5 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 |
0.5 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.5 |
7.7 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.5 |
1.8 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 |
0.5 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.5 |
1.4 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.5 |
1.4 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.5 |
1.8 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.5 |
0.5 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.5 |
2.7 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.5 |
1.4 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 |
1.3 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.4 |
3.6 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.4 |
1.3 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.4 |
7.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 |
1.3 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 |
1.8 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.4 |
2.7 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.4 |
1.8 |
GO:1902962 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 |
0.9 |
GO:0070668 |
regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.4 |
1.3 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.4 |
1.3 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.4 |
6.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.4 |
2.6 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 |
0.4 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.4 |
3.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.4 |
3.5 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
2.2 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.4 |
7.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
5.6 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.4 |
1.7 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.4 |
1.3 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.4 |
1.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.4 |
0.4 |
GO:0070671 |
interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.4 |
3.0 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.4 |
1.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.4 |
0.4 |
GO:0021897 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.4 |
2.2 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.4 |
1.7 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.4 |
0.4 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.4 |
3.8 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.4 |
1.3 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.4 |
5.9 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.4 |
0.8 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.4 |
2.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 |
2.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 |
1.3 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 |
1.7 |
GO:0061290 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
10.1 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.4 |
6.7 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.4 |
2.9 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.4 |
1.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.4 |
1.3 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.4 |
1.7 |
GO:0051808 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.4 |
1.2 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.4 |
0.4 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.4 |
1.7 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.4 |
3.7 |
GO:0042791 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.4 |
1.2 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.4 |
0.8 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.4 |
1.2 |
GO:0042245 |
RNA repair(GO:0042245) |
| 0.4 |
4.9 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.4 |
0.4 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.4 |
2.4 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.4 |
1.6 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.4 |
1.2 |
GO:1901536 |
negative regulation of DNA demethylation(GO:1901536) |
| 0.4 |
3.2 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.4 |
0.8 |
GO:1903516 |
regulation of single strand break repair(GO:1903516) |
| 0.4 |
0.4 |
GO:0006623 |
protein targeting to vacuole(GO:0006623) |
| 0.4 |
1.2 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.4 |
1.6 |
GO:0035350 |
FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.4 |
0.8 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.4 |
4.8 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 |
1.6 |
GO:1905174 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.4 |
1.6 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.4 |
1.6 |
GO:0072423 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.4 |
5.2 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 |
0.8 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.4 |
2.4 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.4 |
1.6 |
GO:0071684 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.4 |
4.0 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 |
1.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 |
0.8 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.4 |
3.9 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.4 |
3.1 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 |
0.4 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.4 |
2.4 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.4 |
1.2 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.4 |
1.6 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.4 |
1.6 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.4 |
2.7 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.4 |
3.5 |
GO:0019049 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.4 |
0.8 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.4 |
1.2 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.4 |
1.6 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.4 |
4.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.4 |
1.6 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.4 |
1.2 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.4 |
1.5 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.4 |
1.2 |
GO:1903567 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.4 |
2.7 |
GO:0071486 |
cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.4 |
1.2 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.4 |
1.2 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.4 |
1.2 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.4 |
0.8 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.4 |
2.3 |
GO:0072434 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.4 |
0.8 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.4 |
3.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 |
1.2 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.4 |
1.9 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 |
1.1 |
GO:1903964 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 |
0.4 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.4 |
4.2 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.4 |
1.5 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.4 |
1.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 |
14.9 |
GO:0061641 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.4 |
1.5 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.4 |
1.9 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.4 |
4.2 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.4 |
12.1 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 |
2.3 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.4 |
1.9 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.4 |
1.5 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.4 |
2.3 |
GO:2000234 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.4 |
1.1 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 |
1.1 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.4 |
13.1 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.4 |
7.1 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.4 |
1.9 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.4 |
1.5 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.4 |
3.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.4 |
0.4 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 |
3.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.4 |
0.7 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.4 |
1.5 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.4 |
5.6 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 0.4 |
1.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.4 |
1.1 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 0.4 |
6.3 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 |
0.4 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.4 |
9.2 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.4 |
2.6 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.4 |
2.2 |
GO:1904207 |
regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.4 |
1.5 |
GO:0002759 |
regulation of antimicrobial humoral response(GO:0002759) |
| 0.4 |
0.7 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
0.4 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.4 |
1.8 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.4 |
2.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.4 |
1.4 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 |
1.1 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.4 |
2.2 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.4 |
2.5 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.4 |
2.1 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.4 |
2.9 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.4 |
2.5 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.4 |
0.7 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.4 |
1.1 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.4 |
0.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.4 |
0.4 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.4 |
0.7 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.4 |
3.9 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 |
5.3 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.4 |
2.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
3.1 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.3 |
3.5 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.3 |
4.5 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.3 |
0.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.3 |
2.1 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.3 |
1.7 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 |
5.6 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.3 |
1.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
2.8 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.3 |
1.4 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.3 |
0.3 |
GO:0033133 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 |
2.1 |
GO:0015878 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.3 |
2.1 |
GO:0043400 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.3 |
1.4 |
GO:0090096 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 |
2.4 |
GO:0042695 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 |
1.0 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.3 |
36.9 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.3 |
1.3 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 |
9.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.3 |
1.0 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.3 |
3.0 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.3 |
1.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.3 |
1.0 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 |
2.3 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 |
0.7 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.3 |
1.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
0.7 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.3 |
1.0 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.3 |
0.7 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.3 |
0.7 |
GO:0001768 |
establishment of T cell polarity(GO:0001768) |
| 0.3 |
0.7 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.3 |
5.6 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 |
0.7 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.3 |
1.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 |
2.0 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.3 |
1.3 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.3 |
1.3 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.3 |
1.6 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 |
0.3 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.3 |
6.2 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.3 |
0.3 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.3 |
1.6 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.3 |
1.0 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.3 |
1.6 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.3 |
3.9 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
0.6 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.3 |
0.6 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.3 |
1.9 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 |
0.6 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.3 |
1.9 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.3 |
1.0 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.3 |
1.0 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 |
4.2 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
5.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.3 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.3 |
5.8 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.3 |
1.3 |
GO:0071043 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.3 |
1.6 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.3 |
2.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
0.3 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.3 |
2.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.3 |
1.3 |
GO:1905044 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.3 |
1.6 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.3 |
3.2 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.3 |
0.9 |
GO:0060254 |
regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.3 |
0.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.3 |
0.3 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.3 |
0.9 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.3 |
0.6 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.3 |
0.6 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.3 |
0.3 |
GO:0003193 |
pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.3 |
1.3 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.3 |
0.6 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.3 |
1.3 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.3 |
2.5 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.3 |
1.2 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.3 |
1.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.3 |
1.5 |
GO:0061083 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 |
3.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 |
0.9 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.3 |
1.9 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 |
0.9 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.3 |
0.6 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.3 |
1.2 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.3 |
2.4 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.3 |
1.8 |
GO:0034959 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 |
2.7 |
GO:1904871 |
regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.3 |
2.1 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.3 |
1.8 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 |
0.3 |
GO:0003213 |
cardiac right atrium morphogenesis(GO:0003213) |
| 0.3 |
0.3 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.3 |
0.6 |
GO:2000570 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.3 |
4.2 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.3 |
1.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.3 |
1.8 |
GO:1904903 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.3 |
0.3 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.3 |
0.9 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.3 |
4.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.3 |
4.5 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.3 |
0.9 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.3 |
1.2 |
GO:0016334 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.3 |
1.2 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.3 |
0.6 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.3 |
0.9 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.3 |
0.6 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.3 |
0.6 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) |
| 0.3 |
4.7 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.3 |
1.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.3 |
1.2 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.3 |
0.6 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.3 |
2.6 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.3 |
3.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.3 |
0.6 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.3 |
2.6 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.3 |
1.5 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.3 |
2.0 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.3 |
0.6 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 |
0.6 |
GO:0009149 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.3 |
0.3 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.3 |
1.2 |
GO:0072144 |
glomerular mesangial cell development(GO:0072144) |
| 0.3 |
1.1 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.3 |
2.3 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
2.0 |
GO:0021834 |
chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.3 |
2.3 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.3 |
2.6 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.3 |
13.9 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.3 |
1.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.3 |
1.7 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.3 |
1.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
1.1 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.3 |
0.3 |
GO:0043201 |
response to leucine(GO:0043201) |
| 0.3 |
5.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.3 |
3.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 |
1.7 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.3 |
1.1 |
GO:0070541 |
response to platinum ion(GO:0070541) |
| 0.3 |
1.1 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 |
2.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.3 |
0.6 |
GO:0022603 |
regulation of anatomical structure morphogenesis(GO:0022603) |
| 0.3 |
1.1 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.3 |
0.6 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 0.3 |
0.6 |
GO:0045829 |
negative regulation of isotype switching(GO:0045829) |
| 0.3 |
1.9 |
GO:0046398 |
UDP-glucuronate metabolic process(GO:0046398) |
| 0.3 |
1.1 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 0.3 |
0.6 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.3 |
0.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
1.6 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.3 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
5.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
1.6 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.3 |
2.5 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.3 |
0.5 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 |
0.5 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 |
0.8 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.3 |
0.5 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.3 |
0.5 |
GO:0048864 |
stem cell development(GO:0048864) |
| 0.3 |
1.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 |
3.2 |
GO:0034626 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
4.8 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.3 |
1.3 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 |
0.8 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.3 |
3.7 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.3 |
0.8 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.3 |
0.8 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.3 |
0.8 |
GO:1903452 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.3 |
1.1 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.3 |
1.6 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.3 |
0.5 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 |
0.3 |
GO:0035935 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.3 |
0.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.3 |
2.6 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.3 |
1.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
1.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 |
1.1 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.3 |
1.3 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.3 |
2.4 |
GO:0061740 |
protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.3 |
1.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
1.3 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.3 |
0.3 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.3 |
1.3 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.3 |
0.8 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 |
7.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
1.0 |
GO:1902809 |
regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.3 |
1.0 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.3 |
4.9 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.3 |
0.3 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.3 |
0.8 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.3 |
5.6 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.3 |
0.8 |
GO:0072684 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.3 |
0.8 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.3 |
0.8 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.3 |
2.5 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.3 |
1.0 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.3 |
1.5 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.3 |
0.5 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.3 |
1.0 |
GO:0005984 |
maltose metabolic process(GO:0000023) disaccharide metabolic process(GO:0005984) |
| 0.3 |
1.3 |
GO:0006499 |
N-terminal protein myristoylation(GO:0006499) |
| 0.3 |
0.3 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.2 |
6.5 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.2 |
3.2 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.2 |
1.0 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.2 |
0.2 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.2 |
1.0 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.2 |
2.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.2 |
0.5 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.2 |
1.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
0.5 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
1.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.2 |
1.0 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.2 |
0.5 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
3.7 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 |
0.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.2 |
2.4 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.2 |
1.9 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
1.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
1.0 |
GO:1900154 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.2 |
0.5 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 |
3.9 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 |
0.2 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.2 |
1.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
0.2 |
GO:0003231 |
cardiac ventricle development(GO:0003231) |
| 0.2 |
0.5 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 |
0.5 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.2 |
0.7 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.2 |
6.3 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.2 |
3.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
1.9 |
GO:0019856 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.2 |
0.5 |
GO:0071901 |
negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.2 |
0.5 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.2 |
3.8 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.2 |
1.4 |
GO:0006335 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
1.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.2 |
1.4 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 |
0.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.7 |
GO:1903674 |
regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.2 |
1.4 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.2 |
2.6 |
GO:0032802 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.2 |
0.9 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
2.4 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.2 |
0.2 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 |
0.7 |
GO:0044782 |
cilium organization(GO:0044782) |
| 0.2 |
0.5 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.2 |
0.2 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
2.6 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 |
0.5 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.2 |
2.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
2.6 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
2.8 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.2 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.2 |
0.9 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 |
0.7 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.2 |
2.1 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
0.5 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.2 |
1.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.5 |
GO:1990180 |
mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 |
8.6 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 |
0.2 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.2 |
0.2 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.2 |
1.4 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
1.8 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
7.4 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.2 |
2.1 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.2 |
0.9 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.7 |
GO:1904317 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.2 |
3.7 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
0.9 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
0.9 |
GO:0072299 |
posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.2 |
2.7 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
5.3 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 |
0.7 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.2 |
2.9 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 |
0.7 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.2 |
0.9 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.2 |
0.9 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
2.5 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.2 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
0.7 |
GO:0046022 |
positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.2 |
2.5 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
2.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.2 |
5.2 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
1.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
1.8 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.2 |
0.7 |
GO:0045083 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.2 |
5.6 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.2 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
1.6 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.2 |
6.9 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.2 |
2.0 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.2 |
1.6 |
GO:1990592 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 |
1.6 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 |
2.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 |
4.4 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
1.3 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
0.4 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.2 |
0.9 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.2 |
0.9 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
0.7 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.2 |
0.7 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.2 |
0.2 |
GO:1904868 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 |
3.7 |
GO:1901620 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.2 |
1.5 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 |
2.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
0.4 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.2 |
2.6 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.2 |
0.4 |
GO:0030216 |
keratinocyte differentiation(GO:0030216) |
| 0.2 |
1.9 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
0.2 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 0.2 |
1.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
1.3 |
GO:0019640 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 |
4.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.2 |
0.9 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.2 |
0.2 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.2 |
0.4 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.2 |
1.7 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
0.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
2.6 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
0.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.2 |
0.6 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.2 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.2 |
1.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.2 |
0.4 |
GO:1903660 |
negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.2 |
0.6 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
4.6 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
1.0 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.2 |
0.8 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.8 |
GO:0021997 |
response to chlorate(GO:0010157) neural plate axis specification(GO:0021997) |
| 0.2 |
7.5 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 |
1.9 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.2 |
5.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.2 |
1.4 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
0.4 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.2 |
1.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
0.8 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
0.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
2.9 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.2 |
1.2 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 |
1.0 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.2 |
1.8 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 |
1.0 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.2 |
0.4 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
1.0 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.2 |
1.2 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.2 |
1.0 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.2 |
0.4 |
GO:1903352 |
L-ornithine transmembrane transport(GO:1903352) |
| 0.2 |
2.2 |
GO:0032264 |
IMP biosynthetic process(GO:0006188) IMP salvage(GO:0032264) |
| 0.2 |
1.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 |
0.2 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
1.0 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.2 |
0.8 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.2 |
2.8 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
0.4 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.2 |
1.6 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
0.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.6 |
GO:0002176 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 |
5.9 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.2 |
0.6 |
GO:0061536 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.2 |
1.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 |
1.0 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.2 |
1.2 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 |
0.4 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.2 |
9.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
4.7 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 |
1.9 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.2 |
0.6 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.2 |
0.8 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.2 |
0.6 |
GO:1902548 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.2 |
4.4 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.2 |
4.0 |
GO:2000810 |
regulation of bicellular tight junction assembly(GO:2000810) |
| 0.2 |
1.7 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.2 |
0.4 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.2 |
3.8 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.2 |
1.9 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 |
3.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
3.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.2 |
1.3 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.2 |
0.8 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 |
0.2 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.2 |
0.4 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.2 |
0.2 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 |
0.4 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.2 |
3.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 |
5.8 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) |
| 0.2 |
1.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.2 |
0.8 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
1.1 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.6 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.2 |
1.3 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
3.0 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
0.4 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
2.4 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
1.1 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.2 |
0.9 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.2 |
2.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.2 |
1.1 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.2 |
1.3 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.2 |
0.7 |
GO:0072183 |
negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.2 |
1.5 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 |
1.8 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 |
0.6 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 |
0.4 |
GO:0071663 |
granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.2 |
3.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.4 |
GO:1903980 |
negative regulation of microglial cell activation(GO:1903979) positive regulation of microglial cell activation(GO:1903980) |
| 0.2 |
1.1 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 |
18.7 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.2 |
2.8 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
0.6 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.2 |
1.1 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 |
0.5 |
GO:0006835 |
dicarboxylic acid transport(GO:0006835) |
| 0.2 |
0.9 |
GO:0030952 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.2 |
2.7 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.2 |
1.8 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
1.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
0.2 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.2 |
0.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
2.0 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.2 |
5.4 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
0.9 |
GO:0042368 |
calcitriol biosynthetic process from calciol(GO:0036378) vitamin D biosynthetic process(GO:0042368) |
| 0.2 |
1.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
1.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
2.0 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.2 |
0.5 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.2 |
1.8 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.2 |
1.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.7 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
2.0 |
GO:0018406 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
1.1 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.2 |
0.2 |
GO:0009886 |
post-embryonic morphogenesis(GO:0009886) |
| 0.2 |
0.4 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.2 |
1.4 |
GO:0061162 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.2 |
2.6 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.2 |
0.9 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.2 |
1.9 |
GO:0021702 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 |
0.4 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.2 |
4.7 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.2 |
1.9 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
0.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.2 |
2.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.2 |
0.2 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.2 |
0.3 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.2 |
5.3 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.2 |
0.7 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 |
0.3 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.2 |
0.3 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 |
1.5 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.2 |
1.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.3 |
GO:2000452 |
CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.2 |
0.5 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.2 |
0.7 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 |
2.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.3 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.2 |
0.5 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 |
3.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 |
1.0 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 |
1.2 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.2 |
0.7 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.5 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 |
0.3 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.2 |
2.7 |
GO:0009157 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.2 |
1.7 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.2 |
4.3 |
GO:0060396 |
growth hormone receptor signaling pathway(GO:0060396) |
| 0.2 |
1.0 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.2 |
1.0 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.2 |
0.3 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
0.7 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.2 |
0.7 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
4.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 |
0.8 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
0.7 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.2 |
0.8 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 |
2.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.5 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
0.2 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.2 |
2.6 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.2 |
1.1 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.2 |
0.5 |
GO:0043473 |
pigmentation(GO:0043473) |
| 0.2 |
0.5 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 |
1.0 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 |
1.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
1.3 |
GO:0060701 |
regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.2 |
0.5 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
1.0 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.2 |
0.2 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.2 |
0.3 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.2 |
0.8 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 |
0.6 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 |
0.3 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.2 |
17.9 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 |
0.9 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
4.6 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
0.6 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.2 |
0.6 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.2 |
0.3 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.2 |
0.2 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.2 |
0.9 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
0.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.2 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.2 |
0.6 |
GO:0003363 |
lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.2 |
2.1 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.2 |
1.4 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.2 |
0.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.2 |
2.0 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.2 |
0.9 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
0.8 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.2 |
0.3 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.2 |
0.5 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
5.9 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.2 |
3.0 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.2 |
0.8 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.3 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.1 |
0.7 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.1 |
0.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.7 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.7 |
GO:0010595 |
positive regulation of endothelial cell migration(GO:0010595) |
| 0.1 |
1.2 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
0.1 |
GO:0050961 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.3 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.7 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.1 |
0.7 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.3 |
GO:0051549 |
positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 |
0.1 |
GO:0043247 |
telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 |
0.1 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.1 |
0.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
1.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.1 |
GO:0016525 |
negative regulation of angiogenesis(GO:0016525) |
| 0.1 |
0.1 |
GO:0010888 |
negative regulation of lipid storage(GO:0010888) |
| 0.1 |
1.5 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.4 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 |
0.7 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
0.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
3.2 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
0.6 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.1 |
0.1 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 |
0.7 |
GO:0010166 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.6 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
0.7 |
GO:2000690 |
regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 |
0.1 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 |
0.6 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.1 |
1.2 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
1.3 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.1 |
4.2 |
GO:0034204 |
lipid translocation(GO:0034204) |
| 0.1 |
0.3 |
GO:0031062 |
positive regulation of histone methylation(GO:0031062) |
| 0.1 |
2.7 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
0.6 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 |
1.1 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.6 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.1 |
0.6 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.4 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
0.7 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.1 |
2.3 |
GO:0035247 |
peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.6 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.6 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 |
0.6 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 |
0.3 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.1 |
1.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
1.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.1 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.4 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.1 |
0.3 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.1 |
4.2 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.1 |
0.4 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.1 |
0.4 |
GO:2000870 |
regulation of progesterone secretion(GO:2000870) |
| 0.1 |
1.3 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 |
0.4 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
0.7 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
2.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
3.2 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.1 |
1.2 |
GO:1901836 |
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.1 |
1.0 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.3 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
2.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
2.1 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
5.9 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.1 |
1.8 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.8 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.1 |
5.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
1.9 |
GO:0018023 |
peptidyl-lysine trimethylation(GO:0018023) |
| 0.1 |
0.7 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.1 |
0.5 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.1 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.1 |
0.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.5 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.1 |
0.1 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
0.4 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.1 |
2.0 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.8 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.1 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.1 |
0.1 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.1 |
0.5 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.1 |
0.1 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
0.9 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.5 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.9 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
1.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
1.1 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.7 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.1 |
0.1 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.1 |
GO:0002554 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.1 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.1 |
0.3 |
GO:0043304 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 |
1.3 |
GO:0034030 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.1 |
2.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 |
1.8 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.8 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 |
0.1 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.1 |
0.9 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.1 |
GO:0072711 |
cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
0.9 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.1 |
0.5 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.1 |
0.3 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.9 |
GO:2000586 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.1 |
2.1 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.1 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
| 0.1 |
0.5 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 |
0.1 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
| 0.1 |
1.0 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.6 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
0.4 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.6 |
GO:0097403 |
cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.1 |
0.6 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.1 |
1.4 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.4 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.3 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.1 |
0.7 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.1 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.4 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 |
0.4 |
GO:0002691 |
regulation of cellular extravasation(GO:0002691) |
| 0.1 |
1.2 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
1.4 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.4 |
GO:0016115 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) terpenoid catabolic process(GO:0016115) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 0.1 |
0.2 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.1 |
0.4 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.1 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.1 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
1.0 |
GO:0070198 |
protein localization to chromosome, telomeric region(GO:0070198) |
| 0.1 |
2.3 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.1 |
GO:0044789 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 |
4.9 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.1 |
0.7 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.1 |
1.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
2.1 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.1 |
0.4 |
GO:0046116 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.5 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 |
0.4 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
1.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.4 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
2.5 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.6 |
GO:2000146 |
negative regulation of cell motility(GO:2000146) |
| 0.1 |
4.9 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.4 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
| 0.1 |
0.8 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.4 |
GO:0002606 |
positive regulation of antigen processing and presentation(GO:0002579) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 |
0.1 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) |
| 0.1 |
1.9 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.1 |
1.3 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
2.0 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
3.0 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.1 |
0.7 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.1 |
1.4 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.1 |
0.5 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.1 |
GO:0002775 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.1 |
0.9 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 |
0.3 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.3 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
2.2 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
1.2 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 |
0.3 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
4.4 |
GO:0051983 |
regulation of chromosome segregation(GO:0051983) |
| 0.1 |
1.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
1.8 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.1 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
3.8 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
1.3 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.3 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.6 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.1 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.1 |
GO:0051586 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 |
0.8 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.8 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 |
0.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
4.9 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.1 |
0.3 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 |
3.5 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.1 |
1.2 |
GO:0072603 |
interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.1 |
0.2 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 |
0.4 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
0.7 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.4 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.1 |
0.3 |
GO:1901799 |
negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.1 |
0.2 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 |
0.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.3 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 |
1.0 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
1.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.4 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.5 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
3.1 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 |
0.2 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.1 |
1.1 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 |
0.7 |
GO:0070586 |
cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 |
0.3 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.1 |
0.2 |
GO:0061355 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.1 |
2.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.3 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 0.1 |
0.3 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 |
0.3 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.1 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 |
0.3 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
0.3 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
1.4 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.3 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.6 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.7 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 |
0.1 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.1 |
0.2 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.1 |
1.3 |
GO:0070072 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.9 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.3 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
2.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.3 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
2.1 |
GO:0006363 |
transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
1.1 |
GO:0043578 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
1.0 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
0.4 |
GO:0039020 |
pronephric nephron tubule development(GO:0039020) |
| 0.1 |
0.3 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.1 |
1.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.4 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.1 |
0.2 |
GO:0035513 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.8 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
6.4 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
0.4 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.1 |
0.1 |
GO:2000232 |
regulation of rRNA processing(GO:2000232) |
| 0.1 |
0.2 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
2.6 |
GO:0043574 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.2 |
GO:1903751 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.1 |
0.3 |
GO:1905053 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.1 |
0.2 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
1.0 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.1 |
0.2 |
GO:0006458 |
'de novo' protein folding(GO:0006458) |
| 0.1 |
1.3 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.3 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.1 |
0.2 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.6 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 |
3.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
2.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.5 |
GO:0097499 |
protein localization to nonmotile primary cilium(GO:0097499) |
| 0.1 |
4.2 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.1 |
0.1 |
GO:0018209 |
peptidyl-serine modification(GO:0018209) |
| 0.1 |
0.2 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.1 |
5.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.3 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
0.7 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.3 |
GO:2000650 |
negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.1 |
0.4 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.1 |
0.6 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
0.3 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.1 |
1.0 |
GO:0061087 |
regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
1.3 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.3 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 |
0.3 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.1 |
1.7 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
5.4 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
0.1 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.1 |
2.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.2 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.6 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
2.0 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
2.4 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
2.2 |
GO:0043090 |
amino acid import(GO:0043090) |
| 0.1 |
0.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.4 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.2 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 |
0.1 |
GO:0048563 |
post-embryonic organ morphogenesis(GO:0048563) |
| 0.1 |
0.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.8 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.5 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.2 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.3 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 |
0.3 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
3.4 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.1 |
0.5 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.3 |
GO:0000730 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.4 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 |
0.2 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.4 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 |
0.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
1.3 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.4 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.1 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) |
| 0.1 |
0.6 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
3.3 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.1 |
0.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.1 |
GO:1902304 |
positive regulation of potassium ion export(GO:1902304) |
| 0.1 |
0.3 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
3.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.4 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.1 |
0.1 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
0.4 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.2 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.4 |
GO:2000637 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.5 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.1 |
0.2 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.1 |
0.1 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.1 |
0.2 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.1 |
0.2 |
GO:1901382 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 |
0.8 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) |
| 0.1 |
0.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
3.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.1 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.1 |
0.7 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
1.1 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.1 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 |
0.2 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 |
0.1 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
0.2 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.4 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 |
1.0 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 |
0.2 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.2 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.1 |
0.5 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.3 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.7 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
1.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.8 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.1 |
3.4 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.1 |
2.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.7 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
1.4 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 0.1 |
0.4 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.6 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.1 |
0.5 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.2 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
1.5 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
2.3 |
GO:0032400 |
melanosome localization(GO:0032400) |
| 0.1 |
0.3 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.2 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.1 |
0.5 |
GO:0048821 |
erythrocyte development(GO:0048821) |
| 0.1 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.5 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.1 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.4 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.1 |
0.2 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
0.1 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.1 |
0.3 |
GO:0033078 |
extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 |
2.0 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 |
0.8 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.5 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.2 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
1.0 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.3 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.1 |
0.2 |
GO:0035572 |
N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 |
0.6 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
1.2 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
0.1 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.1 |
GO:0046877 |
regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
| 0.1 |
0.1 |
GO:0048850 |
hypophysis morphogenesis(GO:0048850) |
| 0.1 |
0.6 |
GO:0035977 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.1 |
0.1 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.1 |
0.7 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.1 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.4 |
GO:0061624 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 |
0.1 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.1 |
0.3 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.1 |
0.4 |
GO:0019566 |
arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.1 |
GO:0018894 |
dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.1 |
0.1 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
3.5 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.1 |
0.2 |
GO:0015740 |
C4-dicarboxylate transport(GO:0015740) |
| 0.1 |
0.4 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.1 |
0.1 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.1 |
0.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
1.0 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
2.4 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.3 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.2 |
GO:0010575 |
positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.1 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
2.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.3 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 |
0.1 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
0.2 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.8 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
2.2 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.4 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.1 |
0.3 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
0.1 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.7 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.8 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.4 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.1 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 |
0.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.1 |
GO:0030238 |
male sex determination(GO:0030238) Leydig cell differentiation(GO:0033327) |
| 0.1 |
0.1 |
GO:0036343 |
psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.1 |
0.3 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.1 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.1 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.1 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.1 |
0.2 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
0.2 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.5 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.1 |
0.1 |
GO:1900040 |
regulation of interleukin-2 secretion(GO:1900040) |
| 0.1 |
0.2 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
1.5 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.8 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.4 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.9 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.1 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.1 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.1 |
0.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.2 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 0.1 |
0.9 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 |
0.4 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.3 |
GO:0019477 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 |
3.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.1 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.3 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.1 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 |
0.5 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.5 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.1 |
0.9 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.1 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.1 |
GO:0071315 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 |
0.4 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
3.5 |
GO:0043647 |
inositol phosphate metabolic process(GO:0043647) |
| 0.1 |
0.9 |
GO:1900077 |
negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 |
0.2 |
GO:0033212 |
iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 0.1 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.3 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 |
1.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
1.5 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.7 |
GO:0014891 |
striated muscle atrophy(GO:0014891) negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 |
0.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.6 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.2 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) |
| 0.1 |
1.4 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.3 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.1 |
0.1 |
GO:1903310 |
positive regulation of chromatin modification(GO:1903310) |
| 0.1 |
0.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 |
0.1 |
GO:0021545 |
cranial nerve development(GO:0021545) |
| 0.1 |
0.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
1.2 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
3.1 |
GO:0030516 |
regulation of axon extension(GO:0030516) |
| 0.1 |
1.0 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
0.2 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.1 |
1.3 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
1.0 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
0.7 |
GO:0002003 |
angiotensin maturation(GO:0002003) |
| 0.1 |
0.1 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.1 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.1 |
1.1 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 |
0.1 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.1 |
0.2 |
GO:0039529 |
RIG-I signaling pathway(GO:0039529) |
| 0.1 |
1.8 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.1 |
0.1 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.2 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.1 |
GO:0002874 |
regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.1 |
0.2 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.1 |
0.6 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.1 |
GO:0052199 |
negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.1 |
0.8 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.2 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.5 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.5 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.1 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.0 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.0 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 |
0.2 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.0 |
GO:0050868 |
negative regulation of T cell activation(GO:0050868) |
| 0.0 |
0.6 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.2 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) |
| 0.0 |
0.0 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.0 |
0.2 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.1 |
GO:0001821 |
histamine secretion(GO:0001821) |
| 0.0 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.0 |
2.1 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.7 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
4.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.0 |
GO:0032330 |
regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 |
0.3 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.1 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.0 |
1.0 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.2 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.2 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.0 |
0.2 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.0 |
0.4 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.1 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.7 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.0 |
0.3 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.0 |
1.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.5 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.1 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.0 |
1.0 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 |
1.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.0 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 |
0.1 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.0 |
0.8 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.1 |
GO:0045064 |
T-helper 2 cell differentiation(GO:0045064) |
| 0.0 |
0.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.0 |
0.0 |
GO:0033121 |
regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.0 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.3 |
GO:0010224 |
response to UV-B(GO:0010224) |
| 0.0 |
0.0 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.0 |
0.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.0 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.0 |
3.1 |
GO:0038096 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 |
0.0 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.1 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.0 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.3 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.3 |
GO:0034628 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.5 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
1.0 |
GO:0035872 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.0 |
0.3 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.1 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.0 |
0.1 |
GO:1990418 |
response to insulin-like growth factor stimulus(GO:1990418) |
| 0.0 |
0.0 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.0 |
0.0 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.2 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.0 |
0.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.6 |
GO:0090342 |
regulation of cell aging(GO:0090342) |
| 0.0 |
0.2 |
GO:0048696 |
collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 |
0.1 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.0 |
0.7 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.0 |
0.2 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.4 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.4 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.1 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.0 |
0.0 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.0 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
1.1 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.0 |
0.0 |
GO:0014016 |
neuroblast differentiation(GO:0014016) |
| 0.0 |
0.3 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.5 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.1 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.0 |
0.2 |
GO:0061458 |
reproductive system development(GO:0061458) |
| 0.0 |
0.3 |
GO:0000003 |
reproduction(GO:0000003) reproductive process(GO:0022414) |
| 0.0 |
0.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 |
0.1 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.3 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.0 |
0.0 |
GO:0052150 |
modulation by symbiont of host apoptotic process(GO:0052150) |
| 0.0 |
0.3 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.0 |
0.1 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.0 |
0.1 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 |
0.6 |
GO:0055092 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 |
0.1 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.0 |
0.7 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.2 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
3.8 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.2 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.1 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.0 |
0.4 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.0 |
0.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.3 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.5 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.1 |
GO:0048512 |
circadian behavior(GO:0048512) |
| 0.0 |
0.0 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
2.6 |
GO:0071427 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.2 |
GO:1901222 |
regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 |
0.0 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.0 |
1.0 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.3 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 |
0.1 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.0 |
0.2 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.3 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.2 |
GO:0042327 |
positive regulation of phosphorylation(GO:0042327) |
| 0.0 |
0.2 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.1 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.0 |
0.4 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.0 |
0.0 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.0 |
GO:0044705 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 |
0.1 |
GO:0021544 |
subpallium development(GO:0021544) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.2 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) |
| 0.0 |
1.6 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.1 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.0 |
0.7 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.0 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.1 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.0 |
0.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:2001138 |
regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.0 |
0.1 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.0 |
0.1 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.0 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.0 |
0.2 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.0 |
0.1 |
GO:0016073 |
snRNA metabolic process(GO:0016073) |
| 0.0 |
0.1 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.3 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.2 |
GO:0033144 |
negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
| 0.0 |
0.1 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.0 |
0.1 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.6 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.1 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.3 |
GO:0006388 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.1 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.0 |
0.1 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.0 |
0.5 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.0 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.0 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 |
0.0 |
GO:0035581 |
sequestering of extracellular ligand from receptor(GO:0035581) |
| 0.0 |
0.7 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.1 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.1 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 |
0.0 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.1 |
GO:0097354 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.2 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.0 |
0.1 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.0 |
0.3 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.0 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.0 |
0.2 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.0 |
1.7 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.0 |
GO:0071288 |
cellular response to mercury ion(GO:0071288) |
| 0.0 |
0.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
1.4 |
GO:0008213 |
protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.0 |
1.9 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.1 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.7 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
1.2 |
GO:0032434 |
regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
| 0.0 |
0.1 |
GO:0031114 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 |
0.1 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.0 |
0.1 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.0 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.0 |
0.3 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.8 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.0 |
0.0 |
GO:0046638 |
positive regulation of alpha-beta T cell differentiation(GO:0046638) |
| 0.0 |
0.0 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 |
0.4 |
GO:0060071 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.0 |
0.2 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.0 |
0.1 |
GO:0033143 |
regulation of intracellular steroid hormone receptor signaling pathway(GO:0033143) |
| 0.0 |
0.1 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.1 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.0 |
0.1 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.1 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 0.0 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.0 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.0 |
0.2 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) |
| 0.0 |
0.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.0 |
0.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.0 |
GO:2001076 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.0 |
0.0 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.0 |
0.1 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.0 |
0.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:0015785 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.0 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.0 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0006863 |
purine nucleobase transport(GO:0006863) |
| 0.0 |
0.1 |
GO:0014831 |
gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.0 |
0.0 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.0 |
0.2 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.0 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.3 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.0 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.0 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.1 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 |
0.0 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.0 |
0.1 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.0 |
0.0 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.6 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.0 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.0 |
0.0 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.0 |
0.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
1.2 |
GO:0044843 |
cell cycle G1/S phase transition(GO:0044843) |
| 0.0 |
0.0 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.2 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.0 |
0.1 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.0 |
GO:1901739 |
regulation of myoblast fusion(GO:1901739) |
| 0.0 |
0.1 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.0 |
0.0 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.0 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.0 |
0.1 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.0 |
0.0 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.1 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.0 |
0.1 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.1 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 |
0.0 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.4 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 |
0.0 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
| 0.0 |
0.1 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.0 |
GO:0007008 |
outer mitochondrial membrane organization(GO:0007008) |
| 0.0 |
0.1 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.0 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.9 |
GO:0021543 |
pallium development(GO:0021543) |
| 0.0 |
0.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.0 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.0 |
0.1 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
3.5 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
0.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
